Werewolf Therapeutics (Series A)
Funding Details
Awarder
Inbox
Date Award
November 20, 2019
Vertical
Biotherapeutics
Funding Amount
$56,000,000
Company Info
Market
Oncology
Location
Cambridge, MA, USA
Coinvestors
Arkin Bio Ventures, DC Investment Partners, Longwood Fund, MPM Capital, Taiho Ventures, UPMC Enterprises
Company Description

Werewolf Therapeutics operates as an oncology biotherapeutics company.